Sarah Zafar

Ms. Sarah Zafar

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2023 in Sustainability
Verified
Journal Article
Open access
PDF file
SZSarah Zafar
Sarah Zafar
SBSaeed Badghish
Saeed Badghish
RYRana Muhammad Shahid Yaqub
Rana Muhammad Shahid Yaqub
MYMuhammad Zafar Yaqub
Muhammad Zafar Yaqub
With tremendous technological advancements, traditional retailing has progressively been transformed into an omnichannel retail environment. While making an appeal to the behavioral reasoning theory, this paper explicates consumers’ (hedonic and utilitarian) value expectations and behavioral reasoning patterns as key antecedents of the maturing of their webrooming intentions in omnichannel environments. Performing PLS-based structural equation modeling on survey data obtained from 470 consumers, it has been found that both the (perceived) value and behavioral reasoning patterns of the consumers exhibit significant direct and indirect effects on building favorable attitudes toward webrooming that eventually lead to the culmination of pro-webrooming intentions. Besides expanding our understanding of the phenomena of interest, this study offers useful insights to marketers/retailers on how to boost pro-webrooming attitudes, intentions, and behaviors by ensuring a superior alignment with (utilitarian and hedonic) value perceptions and pro- and counter-webrooming reasoning patterns of the consumers.

31 December 2021 in Pakistan Armed Forces Medical Journal
Verified
Journal Article
Open access
PDF file
ABAziz Jan Bashir
Aziz Jan Bashir
AHAbdul Hannan
Abdul Hannan
SCSalman Sohail Chaudhary
Salman Sohail Chaudhary
SZSarah Zafar
Sarah Zafar
ASAbdullah Naeem Syed
Abdullah Naeem Syed
SMSyed Hassan Massana
Syed Hassan Massana
Objective: To investigate the effect of unilateral intravitreal Bevacizumab on contralateral eye in bilateral diabetic macular edema. Study Design: Quasi-experimental study. Place and Duration of Study: Retina Department of Al-Shifa Trust Eye Hospital, Rawalpindi, from Sep to Dec 2020. Methodology: Thirty-two patients were enrolled with consecutive sampling. All the patients had clinically diagnosed diabetic macular edema having >275µm macular thickness on OCT. They were injected with 1.25mg/0.05mL of Bevacizumab in one eye. Baseline macular thickness was compared with 4 weeks follow up macular thickness, using Optical Coherence Tomography. Results: The central macular thickness in the untreated eye at baseline was 396.97 ± 29.79 µm and 388.34 ± 30.06 µm at 4 weeks (p-value=0.001). The difference in central macular thickness in treated and untreated eyes were 28.44 ± 4.11 µm and 19.81 ± 5.31 µm respectively (p-value = 0.001). There were statistically significant differences between these measurements. Conclusion: Injecting Bevacizumab in one eye for diabetic macular edema has statistically significant effect on the contralateral non-injected eye macular thickness.